LY3200327

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3200327, covering 2016-09-12 to 2016-09-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3200327 in Healthy Participants [Phase 1]